This study presents a new class of compounds, specifically 5-(Pyrazine-2-yl) 1,3,4-oxadiazol-2-amine and its derivatives, synthesized with aliphatic anhydrides. The successful synthesis is validated through comprehensive characterization involving 1H-NMR, 13C-NMR, FTIR, and Mass Spectra. The synthesized subordinates, represented as formula 3 and 3(a-h), go through orderly assessment for in-vitro antibacterial and antifungal properties against Staphylococcus aureus, Escherichia coli, and Candida albicans. The assessment of antimicrobial activity, conducted through the disc diffusion method with reference compounds, reveals significant efficacy in a majority of the synthesized compounds, with some exhibiting particularly promising results. Molecular docking studies further highlight favourable interactions for all novel compounds. This examination underlines the capability of 5-(Pyrazine-2-yl) 1,3,4-oxadiazol-2-amine subsidiaries against both bacterial and fungal strains.
Read full abstract